Indolent Systemic Mastocytosis — Trials

Indolent Systemic Mastocytosis — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04333108	Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment	unknown	Phase 3	140	AB ScienceINDUSTRY	8	May 6, 2023	clinicaltrials

Data updated 23 days agoSource updated May 6, 2023source: clinicaltrials